XML 87 R2.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 19,960 $ 24,570
Short-term marketable securities 70,791 89,024
Accounts receivable, prepaid expenses and other current assets 5,565 12,357
Total current assets 96,316 125,951
Marketable securities 60,612 90,302
Property and equipment, net 761 1,008
Other assets 2,771 3,066
Total assets 160,460 220,327
Current liabilities:    
Accounts payable 13,158 4,690
Accrued expenses 8,791 20,333
Deferred income 3,943 3,890
Other current liabilities 2,753 2,683
Total current liabilities 28,645 31,596
Other liabilities 1,565 4,439
Deferred income, net of current portion 16,168 20,038
Contingent consideration 11,000 8,700
Total liabilities 57,378 64,773
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at December 31, 2025 and December 31, 2024
Common stock, $0.00001 par value; 400,000,000 and 200,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; 120,499,433 and 107,850,124 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively 1 1
Additional paidin capital 1,070,255 1,058,317
Accumulated other comprehensive income 610 97
Accumulated deficit (967,784) (902,861)
Total stockholders' equity 103,082 155,554
Total liabilities and stockholders' equity $ 160,460 $ 220,327